To Top

Search By Topic

Supply Chain

82 Articles available
Clinical Trial Logistics

Preparing Clinical Trial Logistics for a No-Deal Brexit

PAP-Q4-18-CL-006
Supply Chain

Patient Centricity and the Pharmaceutical Supply Chain: An Evolving Dynamic

PAP-Q3-18-NI-004
Supply Chain

Personalized Logistics Solutions for Virtual and Hybrid Clinical Trials

PAP-Q3-18-CL-002
Design Logic

New Look, Same Unwavering Patient Commitment

PAP-Q3-18-NI-001
Distribution Agreement

Orsini Healthcare Specialty Pharmacy Selected by Alnylam Pharmaceuticals to Distribute ONPATTRO™ (patisiran)

PR-M09-18-NI-019
Logistics

LATAM Cargo Opens Pharma Hub in Denmark

PR-M09-18-NI-073
Marketing Approval

Novadoz Receives Marketing Approval for Generic Versions of Rosuvastatin, Capecitabine, & Moxifloxacin

PR-M08-18-NI-097
Supply Chain

Marken Offers First Hybrid Service from Brazil to USA

PR-M08-18-NI-124
CapsCanada

Building a Robust Supply Chain with Dependable Quality Primary Suppliers

PAO-M07-18-CL-001
Clinical Trials

Marken Announces Plans To Add Nursing Services To Home-Based Trials

PR-M04-18-NI-69
Supply Chain

Overcoming Challenges in the Complex Market for Clinical Trials and Clinical Logistics

PAP-Q1-18-CL-010
Fill/Finish

Getting to the Finish Line

PAP-Q1-18-NI-004
Expanded Capacity

Catalent Completes $4.6 Million Expansion at Singapore Clinical Supply Facility

PR-M03-18-NI-008
Clinical Trials

The UPS Store, Marken Team Up For Drop-Off Service For Clinical Trial Samples In U.S.

PR-M03-18-NI-007
Appointment

Marken Appoints New Vice President, Global Quality Assurance

PR-M02-18-NI-81
Market Expansion

Marken Accelerates Its Reach And Growth In Clinical Trial Logistics

PR-M02-18-NI-031
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Opening

Marken Opens New Location In Stuttgart, Germany

PR-M01-18-NI-083
Merger

CMC Biologics Becomes AGC Biologics

PAO-M01-18-NI-032
Expanded Capacity

Marken Opens New Kit Building Facility In Shanghai

PR-M01-18-NI-057
Partnership

Boehringer Ingelheim and Adimab Partner on Antibodies

PAO-M01-18-NI-030
Pulmonx

Pulmonx Submits Premarket Approval (PMA) Application to U.S. FDA for Zephyr Endobronchial Valve as Treatment for Emphysema

PR-M01-18-NI-039
Joint Venture

WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

PR-M01-18-NI-027
Big Data

Regeneron Forms Consortium of Leading Life Sciences Companies to Accelerate Largest Widely-Available 'Big Data' Human Sequencing Resource with UK Biobank

PR-M01-18-NI-020
Transition

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

PR-M01-18-NI-017
Breakthrough Therapy

AbbVie's Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis

PR-M01-18-NI-018
Denali Therapeutics

Takeda and Denali Therapeutics Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases

PR-M01-18-NI-015
Drug Development

Promacta Gets Breakthrough Therapy Designation

PAO-M01-18-NI-012
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Drug Development

Array BioPharma Forms New Subsidiary Yarra Therapeutics

PAO-M01-18-NI-007
Cell and Gene Therapy

FDA Approves Gene Therapy

PAO-M01-18-NI-005
FDA Guidance

FDA Received Numerous Comments on Its Draft Guidance for Evaluating Biosimilarity

PAO-M01-18-NI-004
Acquisition

Gilead’s new Kite Subsidiary To Buy CAR-T Cell Therapy Company Cell Design Labs

PAO-M01-18-NI-001
Research

Tumor Killing Combo Wins Third U.S. Patent

PAO-M12-17-NI-033
Added Capacity

World’s Largest Biologics Plant Gets EMA Nod

PAO-M12-17-NI-029
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
FDA

New FDA Draft Guidance Intended to Accelerate Development of Drugs for Rare Pediatric Diseases

PAO-M12-17-NI-023
API Manufacturing

BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion

PR-M12-17-NI-013
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
Investment

Bellwyck and Faller Establish Joint Venture in Germany

PR-M11-17-NI-015
Clinical Trials

Managing the Complexities of Outbound Clinical Drug Distribution

PAP-Q4-17-CL-001
Automation

Pharma’s Automation Index on the Rise

PAP-Q4-17-FA-003
Supply Chain

IEEE Releases First Detailed Study of Blockchain Technology in Pharma

PAO-M10-17-NI-027
Logistics

Marken Delivering New Hybrid Service

PR-M09-17-NI-002
Clinical Logistics

Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines

PAP-Q3-17-CL-007
Design Logic

Marken: Stronger Than Ever

PAP-Q3-17-DL-001
CDMO

The CDMO and the International Supply Chain: How Global and Local Relationships are Guiding Sponsors and Providers

PAP-Q3-17-FA-001
CDMO

Benefitting from Embedded Quality for End-to-End Success

Gwenael Servant, Managing Director, Servier CDMO

PTV-M01-17-NS-010
Supply Chain

Increasing Productivity and Profitability

Pamela J. Roach, CEO, Breakthrough Marketing Technology LLC

PTV-M01-17-NS-006
Supply Chain

Direct to Patient Logistics and Technology

Paddy Hanlon, Vice President, Commercial Operations East Coast & Canada, Marken

PTV-M01-17-NS-003
Management

An Inside Look: Strategy at SGS

Fadia Alkhalil-Gadar, VP of Global Business Development, SGS

PTV-M11-16-AP-020
Supply Chain

Keeping the Chain Going

PAP-Q1-17-FA-007

2017 Top 5 Industry Leader

PAP-Q1-17-IL-001
Clinical Trials

Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

PAP-Q1-17-CL-011
Supply Chain

Raw Material Supply: Many Issues to Manage

POP-M10-16-NI-001
Automation

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
CDMO

This Just In

PAP-Q04-16-JI-001
CDMO

Supply Chain Management and the Importance of Security of Supply

PAP-Q04-16-CL-002
Clinical Trials

Perspectives on Product Pricing Strategy and Practice

PAP-Q04-16-NC-001
Equipment

Equipment Redeployment’s Strategic Role

PAP-Q04-16-CL-005
Supply Chain

Rx-360: An Industry Group Like No Other

PAP-Q04-16-CL-007
CDMO

Delivering on Unfulfilled Promises – Building a CDMO

PAP-Q03-16-CL-006
CDMO

Evolving Strategic Partnership Models

PAP-Q03-16-CL-007
Excipients

What Are the Latest Guidelines for Excipients?

POP-M07-16-NI-001
CRO

Strong Growth for CRO Market; Tox Testing Poses Challenges

SCP-M07-16-NI-001
Equipment

2016 Pharmaceutical Equipment Buying Trends

PMP-M08-16-NI-002
Supply Chain

Clinical Logistics – Meeting the 21st Century Cures Challenge

PAP-Q1-16-CL-003
Excipients

Challenges Facing Pharmaceutical Excipients

APR-M05-15-NI-001
Supply Chain

Improving Global Supply Chain Security in the Pharmaceutical Industry

FPP-M04-15-NI-001
Outsourcing

As Outsourcing Relationships Evolve, Vaccine Production Will Continue to Shift to CMOs

LSL-M05-14-NI-002
CMO

Is a CMO With a Global Supply Chain Always the Best Option?

LSL-M11-11-NI-001